HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y-R Liu Selected Research

BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

12/2013Imatinib results in better outcomes than HLA-identical sibling transplants in young persons with newly diagnosed chronic-phase chronic myelogenous leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y-R Liu Research Topics

Disease

1Intervertebral Disc Degeneration
01/2020
1Neoplasms (Cancer)
04/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2019
1Neoplasm Metastasis (Metastasis)
04/2019
1Vascular Malformations
11/2015
1Leukemia
03/2015
1Infections
12/2014
1Varicose Veins (Varicose Vein)
12/2014
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2013
1Weight Gain
02/2010
1Schizophrenia (Dementia Praecox)
02/2010

Drug/Important Bio-Agent (IBA)

1CollagenIBA
01/2020
1Proteoglycans (Proteoglycan)IBA
01/2020
1Circular RNAIBA
04/2019
1CateninsIBA
04/2019
1Radio-Opaque acrylic resinIBA
11/2015
1Fluorescein-5-isothiocyanate (FITC)IBA
03/2015
1Imatinib Mesylate (Gleevec)FDA Link
12/2013
1DNA (Deoxyribonucleic Acid)IBA
02/2010
1Antipsychotic Agents (Antipsychotics)IBA
02/2010

Therapy/Procedure

2Sclerotherapy
11/2015 - 12/2014